参考文献 [1] Ostensen M. New insights into sexual functioning and fertility in rheumatic diseases. Best Pract Res Clin Rheumatol, 2004,18(2):219-32. [2] Mok CC, Wong RW. Pregnancy in systemic lupus erythematosus. Postgrad Med J, 2001,77(905):157-65. [3] Boumpas DT, 3rd AHA, Vaughan EM, et al. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med, 1993,119(5):366-9. [4] Ioannidis JP, Katsifis GE, Tzioufas AG, et al. Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. J Rheumatol, 2002,29(10):2129-35. [5] Carmona F, Font J, Cervera R, et al. Obstetrical outcome of pregnancy in patients with systemic Lupus erythematosus. A study of 60 cases. Eur J Obstet Gynecol Reprod Biol, 1999,83(2):137-42. [6] Cortes-Hernandez J, Ordi-Ros J, Paredes F, et al. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford), 2002,41(6):643-50. [7] Chakravarty EF, Colon I, Langen ES, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol, 2005,192(6):1897-904. [8] Clowse ME, Magder LS, Witter F, et al. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum, 2005,52(2):514-21. [9] Clowse ME, Magder L, Witter F, et al. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum, 2006,54(11):3640-7. [10] Wong KL, Chan FY, Lee CP. Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch Intern Med, 1991,151(2):269-73. [11] Cavallasca JA, Laborde HA, Ruda-Vega H, et al. Maternal and fetal outcomes of 72 pregnancies in Argentine patients with systemic lupus erythematosus (SLE). Clin Rheumatol, 2008,27(1):41-6. [12] Moroni G, Ponticelli C. Pregnancy after lupus nephritis. Lupus, 2005,14(1):89-94. [13] Clark CA, Spitzer KA, Nadler JN, et al. Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol, 2003,30(10):2127-32. [14] Clowse ME, Magder LS, Witter F, et al. Early risk factors for pregnancy loss in lupus. Obstet Gynecol, 2006,107(2 Pt 1):293-9. [15] Moroni G, Ponticelli C. The risk of pregnancy in patients with lupus nephritis. J Nephrol, 2003,16(2):161-7. [16] Huong DL, Wechsler B, Vauthier-Brouzes D, et al. Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre. Ann Rheum Dis, 2001,60(6):599-604. [17] Johnson MJ, Petri M, Witter FR, et al. Evaluation of preterm delivery in a systemic lupus erythematosus pregnancy clinic. Obstet Gynecol, 1995,86(3):396-9. [18] Magid MS, Kaplan C, Sammaritano LR, et al. Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol, 1998,179(1):226-34. [19] Chakravarty EF, Nelson L, Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum, 2006,54(3):899-907. [20] Moroni G, Quaglini S, Banfi G, et al. Pregnancy in lupus nephritis. Am J Kidney Dis, 2002,40(4):713-20. [21] Buyon JP, Kim MY, Copel JA, et al. Anti-Ro/SSA antibodies and congenital heart block: necessary but not sufficient. Arthritis Rheum, 2001,44(8):1723-7. [22] Clowse ME. Lupus activity in pregnancy. Rheum Dis Clin North Am, 2007,33(2):237-52, v. [23] Ruiz-Irastorza G, Khamashta MA, Gordon C, et al. Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale. Arthritis Rheum, 2004,51(1):78-82. [24] Khamashta MA. Systemic lupus erythematosus and pregnancy. Best Pract Res Clin Rheumatol, 2006,20(4):685-94. [25] Costedoat-Chalumeau N, Amoura Z, Duhaut P, et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum, 2003,48(11):3207-11. [26] Fessler BJ, Alarcon GS, McGwin G Jr, et al. Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum, 2005,52(5):1473-80. [27] Clowse ME, Magder L, Witter F, et al. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum, 2006,54(11):3640-7. [28] Tincani A, Danieli E, Nuzzo M, et al. Impact of in utero environment on the offspring of lupus patients. Lupus, 2006,15(11):801-7. [29] Armenti VT, Ahlswede KM, Ahlswede BA, et al. National transplantation Pregnancy Registry--outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation, 1994,57(4):502-6. [30] Shaheen FA, al-Sulaiman MH, al-Khader AA. Long-term nephrotoxicity after exposure to cyclosporine in utero. Transplantation, 1993,56(1):224-5. [31] Khamashta MA. Systemic lupus erythematosus and pregnancy. Best Pract Res Clin Rheumatol, 2006,20(4):685-94. [32] Ostensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther, 2006,8(3):209.